Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new

Inhibrx Biosciences Inc. (INBX : NSD)

Sector: Healthcare

Close
(08-24-2026)
$104.94
Change
$1.31 (1.26%)
Volume 373,412
Open $105.00
Day Range $94.20 - $105.14
52 Week Low $24.27
52 Week High $155.29
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $1,544,471,240
Shares Outstanding 14,717,660
Book Value per Share -$29.15
Earnings per Share -$8.88
Period
Loading......
Loading......

Legend

Inhibrx Biosciences Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
August 24, 2026 104.94
$1.31 (1.26%)
August 21, 2026 103.63
$4.48 (4.52%)
August 20, 2026 99.15
-$2.33 (-2.30%)
August 19, 2026 101.48
$6.86 (7.25%)
August 18, 2026 94.62
$2.61 (2.84%)
August 17, 2026 92.01
$3.64 (4.12%)
August 14, 2026 88.37
-$8.64 (-8.91%)
August 13, 2026 97.01
-$1.35 (-1.37%)
August 12, 2026 98.36
$5.98 (6.47%)
August 11, 2026 92.38
-$0.73 (-0.78%)
August 10, 2026 93.11
$4.45 (5.02%)
August 07, 2026 88.66
$2.87 (3.35%)
August 06, 2026 85.79
$1.90 (2.26%)
August 05, 2026 83.89
$0.36 (0.43%)
August 04, 2026 83.53
$0.81 (0.98%)
August 03, 2026 82.72
$0.67 (0.82%)
July 31, 2026 82.05
-$2.68 (-3.16%)
July 30, 2026 84.73
$5.48 (6.91%)
July 29, 2026 79.25
-$0.43 (-0.54%)
July 28, 2026 79.68
-$2.77 (-3.36%)
July 27, 2026 82.45
$0.90 (1.10%)
July 24, 2026 81.55
-$3.45 (-4.06%)
July 23, 2026 85.00
-$0.92 (-1.07%)
July 22, 2026 85.92
-$1.69 (-1.93%)
July 21, 2026 87.61
$3.52 (4.19%)
July 20, 2026 84.09
-$3.30 (-3.78%)
July 17, 2026 87.39
-$1.68 (-1.89%)
July 16, 2026 89.07
-$2.15 (-2.36%)
July 15, 2026 91.22
-$1.99 (-2.13%)
July 14, 2026 93.21
$1.05 (1.13%)

Funds holding this stock

Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new